Claritev (CTEV) Canaccord Genuity's 46th Annual Growth Conference summary
Event summary combining transcript, slides, and related documents.
Canaccord Genuity's 46th Annual Growth Conference summary
11 Aug, 2026Business overview and transformation
Operates in claims intelligence, provider network, and payment revenue integrity, serving employers, payers, and TPAs.
Launched a services business to integrate solutions across horizontal and vertical strategies.
Underwent significant management changes in the last three to four years, with a new leadership team driving transformation.
Vision 2030 focuses on digital transformation, operational excellence, and business realignment, aiming for completion by 2028.
Migrated tech stack to Oracle Cloud and is rewriting 400 applications to be cloud and AI native.
Financial performance and growth
Achieved five consecutive quarters of growth, with Q2 marking the strongest revenue, EBITDA, and free cash flow in years.
Booked $74 million in new business in the first half of the year, with a multi nine-figure sales funnel.
Pipeline is up 50% year-over-year, with $300 million in active opportunities, $100 million from new verticals.
Confident in reaching the top end of the $80–$100 million bookings target for the year.
Segment-focused sales strategy implemented, with leaders for payer, TPA, provider, public sector, and international channels.
Market expansion and verticals
Won significant contracts, including a top three health system and the World Trade Center Foundation.
TPA segment now represents about 20% of revenue, with a focus on becoming the end-to-end technology provider.
Recognized as a leader in payment and revenue integrity by Everest Group.
New verticals and public sector opportunities are driving pipeline growth.
Latest events from Claritev
- Q2 2026 revenue up 6.6%, guidance raised, but legal and IT risks remain.CTEV
Q2 2026 - Record bookings, tech investment, and strong client ties drive ambitious 2030 growth targets.CTEV
Bank of America Global Healthcare Conference 2026 - Q1 2026 revenue grew 5.8% to $244.7M, with margin gains but continued net losses.CTEV
Q1 2026 - All proposals, including director elections and plan amendments, were approved without contest.CTEV
AGM 2026 - 2026 guidance targets $980M–$1B revenue, 61–62% EBITDA margin, and AI-driven growth.CTEV
Investor Day 2026 - Transformation and innovation drive growth, profitability, and expanded market reach.CTEV
44th Annual J.P. Morgan Healthcare Conference - Six new market segments, tech innovation, and a $200M pipeline drive growth into 2026.CTEV
BofA Securities Leveraged Finance Conference 2025 - Q1 2025 revenue was $231.3M, net loss narrowed, and transformation advanced.CTEV
Q1 2025 - 2024 net loss surged on a $1.49B impairment as transformation and rebranding drive long-term optimism.CTEV
Q4 2024